Live Breaking News & Updates on Drug Eluting Bioadaptor

Stay updated with breaking news from Drug eluting bioadaptor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Elixir Medical Corporation: EuroPCR 2023: Late-Breaking Clinical Data Demonstrate Elixir Medical's DynamX Bioadaptor Restores Vessel Motion and Function with Better Effectiveness at 12 Months Compared to a Leading Drug-Eluting Stent (DES)

First head-to-head randomized clinical trial (RCT) of DynamX Bioadaptor compared to Resolute Onyx DES shows statistically significant effectiveness in restoring vessel pulsatility, achieving significantly ....

United States , Erich Sandoval , Gewinn Nur , Motasim Sirhan , Elixir Medical Corporation , Development Of The Dynamx Bioadaptorthe , Dynamx Bioadaptor , Resolute Onyx , Target Lesion Failure , Drug Eluting Bioadaptor , Eluting Stent , Clinical Safety , Efficacy Results , Device Effectiveness , Vessel Function Results , Plaque Stabilization , Dynamx Bioadaptorthe , Elixir Medical , Dynamx Coronary Bioadaptor System , Medical Corporation ,